A Ser162→Leu mutation within glycoprotein (GP) IIIa (integrin β3) results in an unstable αIIIbβ3 complex that retains partial function in a novel form of type II Glanzmann thrombasthenia

被引:27
作者
Jackson, DE
White, MM
Jennings, LK
Newman, PJ
机构
[1] Blood Ctr SE Wisconsin Inc, Blood Res Inst, Milwaukee, WI 53233 USA
[2] Univ Tennessee, Dept Med, Memphis, TN 38104 USA
[3] Univ Tennessee, Dept Biochem, Memphis, TN 38104 USA
[4] Med Coll Wisconsin, Dept Cellular Biol, Milwaukee, WI 53226 USA
[5] Med Coll Wisconsin, Dept Pharmacol, Milwaukee, WI 53226 USA
关键词
D O I
10.1055/s-0037-1615136
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Platelets from Glanzmann thrombasthenia patient BL express approximately 30% of the normal alpha(II)beta(3) content and support fibrin-mediated clot retraction, but fail to bind fibrinogen or aggregate following cellular activation. BL platelets bind neither activation-dependent nor activation-independent ligands. DNA sequence analysis of BL platelet mRNA revealed a homozygous C-583-->T point mutation in a conserved region of beta(3). resulting in a Ser162Leu amino acid substitution. This mutation appears to produce destabilizing effects on the alpha(IIb)beta(3) complex, as evidenced by the fact that (1) the BL alpha(IIb)beta(3) complex exhibited altered sedimentation velocity through sucrose gradients, (2) alpha(IIb) and beta(3) was not recognized by complex-dependent monoclonal antibodies or co-precipitated by integrin subunit-specific antibodies, and (3) biosynthesis and trafficking of the alpha(IIb)beta(3)Leu(162) complex was delayed relative to that of the wild-type control. Taken together, these data implicate the region encompassing Ser(162) in the stabilization and ligand binding properties of the alpha(IIb)beta(3) complex.
引用
收藏
页码:42 / 48
页数:7
相关论文
共 57 条
[1]  
BAJT ML, 1992, J BIOL CHEM, V267, P3789
[2]  
BENNETT JS, 1982, J BIOL CHEM, V257, P8049
[3]   INHIBITION OF FIBRINOGEN BINDING TO STIMULATED HUMAN-PLATELETS BY A MONOCLONAL-ANTIBODY [J].
BENNETT, JS ;
HOXIE, JA ;
LEITMAN, SF ;
VILAIRE, G ;
CINES, DB .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA-BIOLOGICAL SCIENCES, 1983, 80 (09) :2417-2421
[4]   EXPOSURE OF PLATELET FIBRINOGEN RECEPTORS BY ADP AND EPINEPHRINE [J].
BENNETT, JS ;
VILAIRE, G .
JOURNAL OF CLINICAL INVESTIGATION, 1979, 64 (05) :1393-1401
[5]   BIOGENESIS OF THE PLATELET RECEPTOR FOR FIBRINOGEN - EVIDENCE FOR SEPARATE PRECURSORS FOR GLYCOPROTEINS IIB AND IIIA [J].
BRAY, PF ;
ROSA, JP ;
LINGAPPA, VR ;
KAN, YW ;
MCEVER, RP ;
SHUMAN, MA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1986, 83 (05) :1480-1484
[6]   A DELETION IN THE GENE FOR GLYCOPROTEIN-IIB ASSOCIATED WITH GLANZMANN THROMBASTHENIA [J].
BURK, CD ;
NEWMAN, PJ ;
LYMAN, S ;
GILL, J ;
COLLER, BS ;
PONCZ, M .
JOURNAL OF CLINICAL INVESTIGATION, 1991, 87 (01) :270-276
[7]  
CAEN J, 1972, CLIN HAEMATOL, V1, P383
[8]  
CHARO IF, 1991, J BIOL CHEM, V266, P1415
[9]   SER-752-]PRO MUTATION IN THE CYTOPLASMIC DOMAIN OF INTEGRIN-BETA-3 SUBUNIT AND DEFECTIVE ACTIVATION OF PLATELET INTEGRIN-ALPHA-IIB-BETA-3 (GLYCOPROTEIN-IIB-IIIA) IN A VARIANT OF GLANZMANN THROMBASTHENIA [J].
CHEN, YP ;
DJAFFAR, I ;
PIDARD, D ;
STEINER, B ;
CIEUTAT, AM ;
CAEN, JP ;
ROSA, JP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (21) :10169-10173
[10]  
COLLER BS, 1983, BLOOD, V61, P99